Tag: Ampersand Capital Partners

Ampersand acquires majority stake in in vitro diagnostics company ALPCO

pharmanewsdaily- September 21, 2020

Ampersand Capital Partners, a middle-market private equity firm, has acquired a majority stake in American Laboratory Products Company (ALPCO), an in vitro diagnostics company, for ... Read More

Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn

pallavi123- April 7, 2019

Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about $1.7 billion in cash. Brammer ... Read More